DEVELOPMENT AND MORTALITY OF IXODES DAMMINI

DAMMINI IXODES 的发生和死亡率

基本信息

  • 批准号:
    2066955
  • 负责人:
  • 金额:
    $ 16.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-01-01 至 1997-12-31
  • 项目状态:
    已结题

项目摘要

Lyme disease is now the most common tick borne disease in the United States. Currently, disease prophylaxis has centered mainly on education programs and the personal use of acaricides and repellents on clothing. A number of other strategies have been suggested, many of them involving attempts to reduce tick population abundance. However, the effort is by no means straight forward. Strategies for the management of several tick borne diseases on man and domestic animals benefit from the insights of a considerable theoretical literature on the ecology of the tick species involved. A comparable literature for Ixodes dammini, the tick vector of Lyme borreliosis, does not yet exist and this hampers a priori evaluation of plausible control strategies. We propose to construct a mathematical model for the population biology of I. dammini. This model is the first and essential step in the construction of a useful model for the epizootiology of Lyme borreliosis to be used in the evaluation and development of disease control strategies. The modelling process is predicated upon the measurement of certain critical life-table parameters. We propose to measure the development and mortality of eggs, larvae, nymphs and unfed adults in the laboratory and in the field. We further propose to examine putative mechanisms for the regulation of tick population density. The formal structure of the model will be based on the outcome of the laboratory measures of stage development and survival. The first round of field studies will be used to amend that formal structure so that it more closely mimics events in the field. the second round of field studies will be used to text the adequacy of the model so derived.
莱姆病现在是美国最常见的蜱传疾病

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gary Smith其他文献

Gary Smith的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gary Smith', 18)}}的其他基金

Role of Tumor Stem Cells Recurrent Prostate Cancer
肿瘤干细胞在复发性前列腺癌中的作用
  • 批准号:
    8243675
  • 财政年份:
    2011
  • 资助金额:
    $ 16.56万
  • 项目类别:
Role of Tumor Stem Cells Recurrent Prostate Cancer
肿瘤干细胞在复发性前列腺癌中的作用
  • 批准号:
    7963188
  • 财政年份:
    2010
  • 资助金额:
    $ 16.56万
  • 项目类别:
Hierarchical models for the spatio-temporal dynamics in*
时空动态的分层模型*
  • 批准号:
    7766233
  • 财政年份:
    2006
  • 资助金额:
    $ 16.56万
  • 项目类别:
Hierarchical models for the spatio-temporal dynamics in*
时空动态的分层模型*
  • 批准号:
    7681477
  • 财政年份:
    2006
  • 资助金额:
    $ 16.56万
  • 项目类别:
Hierarchical models for the spatio-temporal dynamics in*
时空动态的分层模型*
  • 批准号:
    7027208
  • 财政年份:
    2006
  • 资助金额:
    $ 16.56万
  • 项目类别:
Hierarchical models for the spatio-temporal dynamics in*
时空动态的分层模型*
  • 批准号:
    7339821
  • 财政年份:
    2006
  • 资助金额:
    $ 16.56万
  • 项目类别:
Hierarchical models for the spatio-temporal dynamics in*
时空动态的分层模型*
  • 批准号:
    7492463
  • 财政年份:
    2006
  • 资助金额:
    $ 16.56万
  • 项目类别:
Hierarchical models for the spatio-temporal dynamics in*
时空动态的分层模型*
  • 批准号:
    7169225
  • 财政年份:
    2006
  • 资助金额:
    $ 16.56万
  • 项目类别:
DEVELOPMENT AND MORTALITY OF IXODES DAMMINI
DAMMINI IXODES 的发生和死亡率
  • 批准号:
    2003730
  • 财政年份:
    1994
  • 资助金额:
    $ 16.56万
  • 项目类别:
DEVELOPMENT AND MORTALITY OF IXODES DAMMINI
DAMMINI IXODES 的发生和死亡率
  • 批准号:
    2066954
  • 财政年份:
    1994
  • 资助金额:
    $ 16.56万
  • 项目类别:

相似海外基金

Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation
异常免疫球蛋白糖基化导致急性莱姆病感染期间的免疫调节
  • 批准号:
    10726417
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease
定义莱姆病肽聚糖诱导的病理生理学的宿主和病原体决定因素
  • 批准号:
    10566961
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome
自身抗体作为治疗后莱姆病综合征的预测标记
  • 批准号:
    10737996
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Neuroimaging and blood markers in post treatment Lyme disease with persistent neurologic symptoms
具有持续神经系统症状的莱姆病治疗后的神经影像学和血液标记物
  • 批准号:
    10745421
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Determinants of Post-Treatment Phenotypes in Lyme Disease
莱姆病治疗后表型的决定因素
  • 批准号:
    10738012
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Elucidating the contributions of c-di-GMP and PlzA to tick- and mammalian host-adaptation in Lyme disease spirochetes
阐明 c-di-GMP 和 PlzA 对莱姆病螺旋体蜱和哺乳动物宿主适应的贡献
  • 批准号:
    10739945
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts
异常肽聚糖片段的自然释放导致易感宿主持续出现莱姆病症状
  • 批准号:
    10736544
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
ImmunoPET Probes for the Imaging of Lyme Disease
用于莱姆病成像的免疫PET探针
  • 批准号:
    10802275
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Unlocking serology’s secrets: harnessing novel immune biomarkers to predict Lyme disease progression and recovery
揭开血清学的秘密:利用新型免疫生物标志物来预测莱姆病的进展和恢复
  • 批准号:
    10737313
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
A novel Lyme disease vaccine
一种新型莱姆病疫苗
  • 批准号:
    10515700
  • 财政年份:
    2022
  • 资助金额:
    $ 16.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了